(b) Placebo group (n = 26)
| Baseline | After 12 weeks | p value | |
|---|---|---|---|
| Fasting glucose, mg/dL | 88.12 ± 7.95 | 89.61 ± 6.24 | 0.210 |
| Plasma insulin, μU/dL | 5.89 ± 2.43 | 5.85 ± 1.97 | 0.927 |
| HbA1c, % | 5.61 ± 0.49 | 5.61 ± 0.42 | 1.000 |
| Triglyceride, mg/dL | 81.96 ± 40.95 | 77.81 ± 45.09 | 0.449 |
| Total cholesterol, mg/dL | 183.31 ± 26.70 | 187.77 ± 28.20 | 0.231 |
| LDL cholesterol, mg/dL | 115.12 ± 27.23 | 116.96 ± 30.05 | 0.588 |
| HDL cholesterol, mg/dL | 57.77 ± 11.17 | 57.77 ± 9.99 | 1.000 |
Data are expressed as means ± standard deviations.
p values were calculated with paired t-test for continuous variables.
LDL, low density lipoprotein; HDL, high density lipoprotein.